Literature DB >> 3918706

Graft versus host diseases: new versions of old problems?

A M Denman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918706      PMCID: PMC1417659          DOI: 10.1136/bmj.290.6469.658

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  39 in total

1.  Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.

Authors:  R Champlin; W Ho; R P Gale
Journal:  N Engl J Med       Date:  1983-01-20       Impact factor: 91.245

2.  Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: a case report with in vitro marrow culture studies.

Authors:  J W Singer; A Keating; R Ramberg; R McGuffin; J E Sanders; G Sale; P J Fialkow; E D Thomas
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

Review 3.  Allogenic bone marrow transplantation: current status and future directions.

Authors:  R J O'Reilly
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

4.  Scleroderma-like changes due to chronic graft-versus-host disease.

Authors:  R A Graham-Brown; I Sarkany
Journal:  Clin Exp Dermatol       Date:  1983-09       Impact factor: 3.470

Review 5.  Bone marrow transplantation: a review of delayed complications.

Authors:  H J Deeg; R Storb; E D Thomas
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

6.  Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease.

Authors:  A H Filipovich; D A Vallera; R J Youle; R R Quinones; D M Neville; J H Kersey
Journal:  Lancet       Date:  1984-03-03       Impact factor: 79.321

7.  Cellular interactions in marrow-grafted patients. II. Normal monocyte antigen-presenting and defective T-cell-proliferative functions early after grafting and during chronic graft-versus-host disease.

Authors:  M S Tsoi; S Dobbs; S Brkic; R Ramberg; E D Thomas; R Storb
Journal:  Transplantation       Date:  1984-06       Impact factor: 4.939

8.  Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia.

Authors:  B Camitta; R J O'Reilly; L Sensenbrenner; J Rappeport; R Champlin; K Doney; C August; R G Hoffmann; D Kirkpatrick; R Stuart; G Santos; R Parkman; R P Gale; R Storb; D Nathan
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

9.  Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement.

Authors:  G Hale; S Bright; G Chumbley; T Hoang; D Metcalf; A J Munro; H Waldmann
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

10.  Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

Authors:  R L Powles; H M Clink; D Spence; G Morgenstern; J G Watson; P J Selby; M Woods; A Barrett; B Jameson; J Sloane; S D Lawler; H E Kay; D Lawson; T J McElwain; P Alexander
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

View more
  2 in total

Review 1.  Graft versus leukemia in bone marrow transplantation.

Authors:  M Boranić
Journal:  Blut       Date:  1988-08

2.  Modulation of in vitro myelopoiesis by alloreactive T cell clones.

Authors:  F W Busch; P Wernet; P Meyer; E M Schneider; G Pawelec
Journal:  Blut       Date:  1986-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.